Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution
160001
Phase 2 small_molecule completed
Quick answer
Immune Globulin Intravenous (Human), 10% TVR (Triple Virally Reduced) Solution for Primary Immunodeficiency Diseases (PID) is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Primary Immunodeficiency Diseases (PID)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed